• Home
  • About Us
    • What We Do
    • Management Team
    • Contact Us
  • REMS Solutions
    • REMS Assessments
    • REMS Consulting Services
    • ETASU Programs
    • Recent Examples
  • Observational Research
    • Labeling Comprehension Studies
    • Usability Studies
    • Patient Reported Outcomes
    • Market Research
    • Recent Examples
    • Case Studies
  • Resource Center
    • Recent Development & News
    • Videos
    • Articles
    • Presentations
    • Blog
    • REMSadvisor.com

Resource Center

  • Recent Posts

    • REMS Assessments: Insights, Strategies and the Moving Target
    • BioTrak announces the launch of a new dedicated REMS information site
    • Webinar: "Tackling the #1 Misunderstood REMS Requirement"
  • RSS REMS Zone

    • World Drug Safety Conference
    • The Safety Continuum in the Medical Product Life Cycle
    • CBI’s 13th Bio/Pharmaceutical and Medical Device Registries and Post Approval Studies Congress
    • Discussion Forum
    • FDA Proposes Withdrawal of Low Blood Pressure Drug

BioTrak announces the launch of a new dedicated REMS information site


REMSadvisor.com is an information recourse site for FDA REMS.

Click on the image to visit REMSadvisor.com

Leave a Reply

Click here to cancel reply.

    • Home
    • About Us
      • What We Do
      • Management Team
      • Contact Us
    • REMS Solutions
      • REMS Assessments
      • REMS Consulting Services
      • ETASU Programs
      • Recent Examples
    • Observational Research
      • Labeling Comprehension Studies
      • Usability Studies
      • Patient Reported Outcomes
      • Market Research
      • Recent Examples
      • Case Studies
    • Resource Center
      • Recent News & Developments
      • Videos
      • Articles
      • Presentations
      • Blog
      • REMSadvisor.com
Subscribe to our RSS Feed Contact Us

5927 Balfour Court, Suite 201 Carlsbad, CA 92008·Tel: 760.448.4820·Fax: 760.603.9535·contactus@biotrak.com

BioTrak Copyright 2010